Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Decreased by Weaver C. Barksdale & Associates Inc.

Weaver C. Barksdale & Associates Inc. reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 20.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 25,746 shares of the biopharmaceutical company’s stock after selling 6,786 shares during the quarter. Gilead Sciences makes up about 2.0% of Weaver C. Barksdale & Associates Inc.’s […]

Related Keywords

United States ,Canada ,Merdad Parsey ,Complera Eviplera ,Wealth Management Group ,Cantor Fitzgerald ,News Ratings For Gilead Sciences Daily ,Barclays ,Gilead Sciences ,Gilead Sciences Inc ,Nasdaq ,Fortitude Family Office ,Tompkins Financial Corp ,Weaverc Barksdale Associates Inc ,Royal Bank ,Quarter For Gilead Sciences ,Gilead Sciences Stock Performance ,Insider Transactions At Gilead Sciences ,Gilead Sciences Dividend Announcement ,Free Report ,Financial Corp ,Asset Management ,Family Office ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,